Autophagy and pressure overload-induced cardiac hypertrophy
Related Experiment Video
Updated: Oct 6, 2025

Magnetic Adjustment of Afterload in Engineered Heart Tissues
Published on: May 5, 2020
Yong Zeng1, Wei-Qiong Ren1, Ai-Zhen Wen1
1The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha 410007, China.
Insights
Autophagy, a cellular process, is crucial in cardiovascular disease. This review explores how regulating autophagy may treat cardiac hypertrophy, despite conflicting research findings.
Area of Science:
- Cardiovascular Biology
- Cellular Biology
- Molecular Medicine
Background:
- Autophagy is implicated in cardiovascular disease pathogenesis.
- The role of autophagy in cardiac hypertrophy is complex and contradictory, with some studies showing protective effects of activation and others suggesting inhibition is beneficial.
- Understanding these discrepancies is key to developing effective treatments.
Approach:
- This review synthesizes current research on autophagy and cardiac hypertrophy.
- It examines various pathways and molecular mechanisms involved in the autophagy-hypertrophy relationship.
- The focus is on identifying potential therapeutic targets for intervention.
Key Points:
- Autophagy dysregulation significantly impacts pressure overload-induced cardiac hypertrophy.
- Conflicting findings in existing literature may stem from different experimental models or pathways studied.
- Targeting specific autophagy pathways holds promise for alleviating cardiac hypertrophy.
Conclusions:
- Cardiac hypertrophy can potentially be managed by modulating autophagy.
- Further research is needed to elucidate the precise mechanisms and optimize therapeutic strategies.
- This review highlights key pathways and targets for future drug development in treating cardiac hypertrophy.
Abstract:
Autophagy plays an important role in the pathogenesis of cardiovascular diseases. Dysregulation of autophagy may have a huge effect on cardiac hypertrophy induced by overload pressure although reports on autophagy and cardiac hypertrophy have been contradictory. Some studies showed that autophagy activation attenuated cardiac hypertrophy. However, others suggested that inhibition of autophagy would be protective. Different research models or different pathways involved could be responsible for it. Cardiac hypertrophy may be alleviated through regulation of autophagy. This review aims to highlight the pathways and therapeutic targets identified in the prevention and treatment of cardiac hypertrophy by regulating autophagy.
More Related Videos
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

